Objectives: Myasthenia gravis (MG) is an autoimmune disease accompanied by a thymic pathology and in most patients thymectomy (TE) is used as the therapeutic approach. Both B and T cells play an important role in MG pathogenesis.
Methods: Twelve pre- and post-TE MG patients and 12 healthy controls (HCs) were enrolled.